Effects of circulating and local uteroplacental angiotensin ii in rat pregnancy

Hypertension

Volumn 56, Issue 2, 2010, Pages 311-318

  Hering, Lydia ^a   Herse, Florian ^a   Geusens, Nele ^b   Verlohren, Stefan ^a   Wenzel, Katrin ^a   Staff, Anne C ^d   Brosnihan, K Bridget ^e   Huppertz, Berthold ^f   Luft, Friedrich C ^a   Muller, Dominik N ^a   Pijnenborg, Robert ^b   Cartwright, Judith E ^c   Dechend, Ralf ^a,g  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g Helios Klinikum   (Germany)

Author keywords

angiotensin II; decidua; placenta; preeclampsia; transgenic rats; trophoblasts; vascular remodeling

Indexed keywords

ANGIOTENSIN II; RENIN; ANGIOTENSINOGEN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROSCOPY; NONHUMAN; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TROPHOBLAST; UTERINE ARTERY; ANIMAL; BLOOD; BRAIN; BREEDING; CELL MOTION; CROSS BREEDING; DRUG EFFECT; GENETICS; HISTOLOGY; INTRAUTERINE GROWTH RETARDATION; LIVER; PATHOLOGY; PHYSIOLOGY; PLACENTA; PRENATAL DEVELOPMENT; TRANSGENIC ANIMAL; UPREGULATION; UTERUS;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; CELL MOVEMENT; CROSSES, GENETIC; FEMALE; FETAL GROWTH RETARDATION; HUMANS; LIVER; MALE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; RATS; RENIN; TROPHOBLASTS; UP-REGULATION; UTERUS;

EID: 77955505983     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.150961     Document Type: Article

References (38)

1. Davison JM, Homuth V, Jeyabalan A, Conrad KP, Karumanchi SA, Quaggin S, Dechend R, Luft FC. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol. 2004;15:2440-2448.
2. Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med. 2006;355:1056-1058.
3. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoan-tibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14: 855-862.
4. Dechend R, Gratze P, Wallukat G, Shagdarsuren E, Plehm R, Brasen JH, Fiebeler A, Schneider W, Caluwaerts S, Vercruysse L, Pijnenborg R, Luft FC, Muller DN. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension. 2005;45:742-746.
5. Geusens N, Verlohren S, Luyten C, Taube M, Hering L, Vercruysse L, Hanssens M, Dudenhausen JW, Dechend R, Pijnenborg R. Endovascular trophoblast invasion, spiral artery remodelling and uteroplacental haemo-dynamics in a transgenic rat model of pre-eclampsia. Placenta. 2008;29: 614-623.
6. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594.
7. Anton L, Brosnihan KB. Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2008;2:349-362.
8. Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29:763-771.
9. LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51:982-988.
10. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol. 2005;288:F614-F625.
11. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension. 2007;49:604-611.
12. Bohlender J, Ganten D, Luft FC. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol. 2000;11:2056-2061.
13. Verlohren S, Niehoff M, Hering L, Geusens N, Herse F, Tintu AN, Plagemann A, LeNoble F, Pijnenborg R, Muller DN, Luft FC, Duden-hausen JW, Gollasch M, Dechend R. Uterine vascular function in a transgenic preeclampsia rat model. Hypertension. 2008;51:547-553.
14. Geusens N, Hering L, Verlohren S, Luyten C, Drijkoningen K, Taube M, Vercruysse L, Hanssens M, Dechend R, Pijnenborg R. Changes in endo-vascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model. Placenta. 2010;31:320-326.
15. Harris LK, Keogh RJ, Wareing M, Baker PN, Cartwright JE, Aplin JD, Whitley GS. Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism. Am J Pathol. 2006;169: 1863-1874.
16. Ashton SV, Whitley GS, Dash PR, Wareing M, Crocker IP, Baker PN, Cartwright JE. Uterine spiral artery remodeling involves endothelial apo-ptosis induced by extravillous trophoblasts through Fas/FasL interactions. Arterioscler Thromb Vasc Biol. 2005;25:102-108.
17. Baczyk D, Dunk C, Huppertz B, Maxwell C, Reister F, Giannoulias D, Kingdom JC. Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. Placenta. 2006;27:367-374.
18. Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R. Interstitial tro-phoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta. 2006;27:22-33.
19. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.
20. Rosenfeld CR, Gant NF Jr. The chronically instrumental ewe: a model for studying vascular reactivity to angiotensin II in pregnancy. J Clin Invest. 1981;67:486-492.
21. Ferris TF, Stein JH, Kauffman J. Uterine blood flow and uterine renin secretion. J Clin Invest. 1972;51:2827-2833.
22. Li C, Ansari R, Yu Z, Shah D. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension. 2000; 36:159-164.
23. Brosnihan KB, Hering L, Dechend R, Chappell MC, Herse F. Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia. Hypertension. 2010;55:562-566.
24. Morgan T, Craven C, Nelson L, Lalouel JM, Ward K. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest. 1997;100:1406-1415.
25. Bischof P, Meisser A, Campana A. Biochemistry and molecular biology of trophoblast invasion. Ann N Y Acad Sci. 2001;943:157-162.
26. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27:939-958.
27. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46:1243-1249.
28. Shibata E, Powers RW, Rajakumar A, von Versen-Hoynck F, Gallaher MJ, Lykins DL, Roberts JM, Hubel CA. Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation. Am J Physiol Endocrinol Metab. 2006;291: E1009-E1016.
29. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angio-tensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2007;112:417-428.
30. Xia Y, Wen HY, Kellems RE. Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation. J Biol Chem. 2002;277: 24601-24608.
31. Ishimatsu S, Itakura A, Okada M, Kotani T, Iwase A, Kajiyama H, Ino K, Kikkawa F. Angiotensin II augmented migration and invasion of chorio-carcinoma cells involves PI3K activation through the AT1 receptor. Placenta. 2006;27:587-591.
32. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest. 1997;99:2139-2151.
33. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-2387.
34. LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor ain pregnant rats. Hypertension. 2008;52:1168-1172.
35. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB. The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy. Endocrinology. 2009;150:4316-4325.
36. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274:995-998.
37. Furuya M, Ishida J, Inaba S, Kasuya Y, Kimura S, Nemori R, Fukamizu A. Impaired placental neovascularization in mice with pregnancy-associated hypertension. Lab Invest. 2008;88:416-429.
38. Saito T, Ishida J, Takimoto-Ohnishi E, Takamine S, Shimizu T, Sugaya T, Kato H, Matsuoka T, Nangaku M, Kon Y, Sugiyama F, Yagami K, Fukamizu A. An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. Faseb J. 2004;18:388-390.